Name: A Guidebook to Generic Drug registration in India (en Inglés)
Price: 1678.21 MXN
Availability: InStock
Author: Behera, Chinmaya Chidananda ; Sahu, Susanta Kumar ; Nandi, Prafulla Kumar
ISBN: 9786139962495

Envío gratis

portada A Guidebook to Generic Drug registration in India (en Inglés)

Formato

Libro Físico

Autor

Chinmaya Chidananda Behera

Susanta Kumar Sahu

Prafulla Kumar Nandi

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

200

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 1.2 cm

Peso

0.30 kg.

ISBN13

9786139962495

Categorías

Farmacología

A Guidebook to Generic Drug registration in India (en Inglés)

Chinmaya Chidananda Behera (Autor) · Susanta Kumar Sahu (Autor) · Prafulla Kumar Nandi (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo

$ 1,678.21

$ 2,797.02

Ahorras: $ 1,118.81

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 29 de Julio y el Martes 06 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "A Guidebook to Generic Drug registration in India (en Inglés)"

Since drugs are so-called life-saving substances, the quality, safety, and efficacy of these substances pose a unique challenge for the manufacturers as well as regulators. The drug has to undergo several phases of screening by governmental agencies before it is being placed in the market. A country like India's skill mostly lies in developing low priced generic medicines. Our infrastructure and economy do not allow us to invest like the western countries. The quality of medicines produced in India is no way inferior to any of the medicines available globally. However irony of the situation is such that India produces the best quality medicine for the world, not for itself. This is primarily because of the reason that it does not have a standard for itself. All the countries in the world starting from highly regulated markets to less regulated market have a certain form of guidelines for registration of the drugs in their own territories. This current work proposes some guidelines those can be adapted by Indian Regulatory authorities so as to enhance the quality of pharmaceutical products in India to meet international standards.